VIR

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Vir Biotechnology (VIR) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

VIR is expected to report earnings to fall 42.72% to -89 cents per share on February 20

Vir Biotechnology VIR Stock Earnings Reports

Q4'24

Est.

$-0.89

Q3'24

Missed

by $0.51

Q2'24

Missed

by $0.13

Q1'24

Beat

by $0.57

Q4'23

Beat

by $0.22

The last earnings report on October 31 showed earnings per share of -155 cents, missing the estimate of -104 cents. With 766.27K shares outstanding, the current market capitalization sits at 1.19B.

View a ticker or compare two or three

Compare

VIR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For VIR
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for VIR (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1800 Owens Street

Phone

+1 415 906-4324

Employees

587

Web

https://www.vir.bio